At a glance

ClinicalIndex Comparison Record

Phase 3Completed· 641 enrolled

Drug / intervention

Zinc (zinc sulphate) +1 moredrug

Likely dose

Zinc (zinc sulphate) 10 mgfrom record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00252304

NCT00252304Phase 3Completed

Compare CT.gov

Efficacy of Zinc as Adjuvant Therapy in the Treatment of Severe Pneumonia in Nepalese Children at the Kanti Children's Hospital

Centre For International Health·interventional·Posted Nov 11, 2005·Updated Oct 6, 2009

In Brief

A Phase 3 clinical trial evaluating Zinc (zinc sulphate) and Placebo for Pneumonia. Completed, enrolled 641 participants across 1 site.

Detailed Summary

The aim of this study is to assess whether zinc given as adjuvant therapy to standard antibiotic treatment in children hospitalized for severe pneumonia reduces the duration of the severe illness and risk of treatment failure. A randomized double blind placebo controlled clinical trial will be conducted at the Kanti Hospital.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsPneumonia

CountriesNepal

CollaboratorsTribhuvan University, Nepal, Statens Serum Institut, All India Institute of Medical Sciences, Institut de Recherche pour le Developpement, Society for Applied Studies

Timeline

Phase 3CompletedFinished

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

First PostedNov 2005

Enrollment StartJan 2006

Primary CompletionJul 2008

TodayJul 2026

First PostedNov 11, 2005

Enrollment StartJan 1, 2006

Primary CompletionJul 1, 2008

TodayJul 2, 2026

Enrollment to primary: 2.5 yearsPosted 20.6 years ago

Interventions

Zinc (zinc sulphate)drug

Dissolvable zinc tablet 10 mg elemental zinc per day for infants 20 mg elemental zinc per day for children 12 to 35 months

Placebodrug

Placebo